Most-recognized brands: Anti-infectives, December 2013

joshua.slatko

The most-recognized anti-infective brand in North America is Cipro. The brand was most-recognized by 7 percent of physicians in a survey conducted by Brand Institute Inc. during the second quarter of . Cipro, comprising ciprofloxacin, is marketed by Bayer HealthCare Pharmaceuticals (bayerhealthcare.com). The drug was first approved by FDA in 1987 and has earned indications for the treatment of a variety of bacterial infections, including anthrax.

Levaquin is the second most-recognized anti-infective brand in North America. About 5.5 percent of physicians recognize this brand the most. Levaquin, comprising levofloxacin, is marketed by Ortho-McNeil Pharmaceutical Inc. (ortho-mcneilpharmaceutical.com) and PriCara Inc. (pricara.com), both subsidiaries of Johnson & Johnson (jnj.com). The product was first approved by FDA in 1996, and its various formulations have been approved for 28 different anti-infective indications. Levaquin’s most recent new indications came in September 2007, when the drug was approved for the treatment of acute pyelonephritis and for the treatment of complicated urinary tract infection.

The third most-recognized anti-infective brand in Europe is Augmentin. About 4.3 percent of physicians recognize this brand the most. Augmentin, comprising amoxicillin and clavulanate, is marketed by GlaxoSmithKline (gsk.com). The drug was first approved in 1984 and has earned more than 25 anti-infective indications.

The most-recognized anti-infective brand in Europe is Augmentin. About 5.2 percent of physicians recognize this brand the most.
Amoxil is the second most-recognized anti-infective brand in Europe. About 2.6 percent of physicians recognize this brand the most. Amoxil, comprising amoxicillin, is marketed in Europe by GlaxoSmithKline and in the United States by Dr. Reddy’s Laboratories Inc. (drreddys.com). Discovered by scientists at Beecham Research Laboratories in 1972, amoxicillin is one of the world’s…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS